Illumina Has Appointed Jacob Thaysen, Senior Vice President Of Agilent Technologies And President Of Its Life Sciences And Applied Markets Group, As Chief Executive Officer, Effective September 25, 2023
Portfolio Pulse from Benzinga Newsdesk
Illumina has announced the appointment of Jacob Thaysen, currently Senior Vice President of Agilent Technologies and President of its Life Sciences and Applied Markets Group, as its new CEO, effective from September 25, 2023.
September 05, 2023 | 11:37 am
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Illumina's appointment of Jacob Thaysen as CEO could bring new strategic direction to the company, potentially impacting its stock performance.
The appointment of a new CEO often brings changes in strategic direction, which can impact a company's performance and stock price. However, the exact impact on Illumina's stock will depend on the market's perception of Thaysen's ability to lead the company.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 100